Mirum Pharmaceuticals (MIRM) Revenue (2021 - 2025)
Historic Revenue for Mirum Pharmaceuticals (MIRM) over the last 5 years, with Q3 2025 value amounting to $133.0 million.
- Mirum Pharmaceuticals' Revenue rose 4717.24% to $133.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $471.8 million, marking a year-over-year increase of 5366.48%. This contributed to the annual value of $336.9 million for FY2024, which is 8075.91% up from last year.
- Latest data reveals that Mirum Pharmaceuticals reported Revenue of $133.0 million as of Q3 2025, which was up 4717.24% from $127.8 million recorded in Q2 2025.
- Mirum Pharmaceuticals' 5-year Revenue high stood at $133.0 million for Q3 2025, and its period low was $3.1 million during Q4 2021.
- For the 5-year period, Mirum Pharmaceuticals' Revenue averaged around $55.1 million, with its median value being $42.6 million (2023).
- In the last 5 years, Mirum Pharmaceuticals' Revenue surged by 78929.25% in 2022 and then surged by 4293.07% in 2024.
- Mirum Pharmaceuticals' Revenue (Quarter) stood at $3.1 million in 2021, then skyrocketed by 789.29% to $27.9 million in 2022, then surged by 149.24% to $69.6 million in 2023, then surged by 42.93% to $99.4 million in 2024, then surged by 33.79% to $133.0 million in 2025.
- Its Revenue was $133.0 million in Q3 2025, compared to $127.8 million in Q2 2025 and $111.6 million in Q1 2025.